Occudo Quantitative Strategies LP Kronos Bio, Inc. Transaction History

Occudo Quantitative Strategies LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.34 - $2.62 $17,466 - $34,151	13,035 Added 55.43%	36,552 $53,000
Q4 2022 Feb 14, 2023	SELL	$1.44 - $3.44 $12,761 - $30,485	-8,862 Reduced 27.37%	23,517 $38,000
Q3 2022 Nov 14, 2022	SELL	$3.35 - $5.55 $139,969 - $231,890	-41,782 Reduced 56.34%	32,379 $108,000
Q2 2022 Aug 15, 2022	BUY	$3.12 - $7.52 $231,382 - $557,690	74,161 New	74,161 $270,000

19.8M

9.3K

100

Ticker KRON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,769,100
Market Cap $54.5M
Description
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.